FindTrial
Sign In

Construction and application of early intervention scheme for postpartum hemorrhage during vaginal delivery

Construction and application of evidence-based early intervention program for postpartum hemorrhage during vaginal delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110845
Enrollment
Unknown
Registered
2025-10-21
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum hemorrhage

Interventions

Trial group:The intervention group received the newly developed "Early Intervention and Management Protocol for Postpartum Hemorrhage Following Vaginal Delivery" established in this study. The protoco
Control group:The control group received the current postpartum hemorrhage (PPH) intervention protocol for vaginal delivery at our hospital, which primarily includes: immediate intravenous infusion of

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Vaginal delivery was performed in our hospital from September 1, 2024 to March 31, 2025. 2.Be able to move freely, have healthy limbs and voluntarily choose vaginal delivery; 3.Clear consciousness, capable of clearly expressing one's own condition, cooperating to complete physical assessment tests and intervention. 4.After being informed of the relevant precautions, voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Those who switch to cesarean section during vaginal delivery due to actual circumstances; 2.Those with a family history of mental illness, neurasthenia, stress disorders, personality disorders, and diseases caused by taking psychoactive substances; 3.hose with malignant tumors or other serious wasting diseases, insufficient cerebral blood supply (such as cervical spondylosis of the vertebral artery type), infectious diseases, neurological diseases, mental disorders, severe cardiovascular, liver, kidney, gastrointestinal, blood system diseases, musculoskeletal system diseases and other contraindications for exercise who are not suitable for vaginal delivery; 4.Participants in other clinical trials that affect the evaluation of the results of this study.

Design outcomes

Primary

MeasureTime frame
Postpartum blood loss;Blood transfusion volume;Postpartum hemorrhage rate;Severe postpartum hemorrhage rate;—

Countries

China

Contacts

Public ContactChen Yanting

China-Japan Friendship Hospital

chenyanting315@163.com+86 13331058159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026